Mark Sumeray

2014

In 2014, Mark Sumeray earned a total compensation of $1.6M as former Chief Medical Officer at Aegerion Pharmaceuticals, a 47% decrease compared to previous year.

Compensation breakdown

Option Awards$1,141,936
Salary$405,000
Other$75,175
Total$1,622,111

Sumeray received $1.1M in option awards, accounting for 70% of the total pay in 2014.

Sumeray also received $405K in salary and $75.2K in other compensation.

Rankings

In 2014, Mark Sumeray's compensation ranked 5,424th out of 13,032 executives tracked by ExecPay. In other words, Sumeray earned more than 58.4% of executives.

ClassificationRankingPercentile
All
5,424
out of 13,032
58th
Division
Manufacturing
1,939
out of 4,966
61st
Major group
Chemicals And Allied Products
654
out of 1,686
61st
Industry group
Drugs
504
out of 1,365
63rd
Industry
Pharmaceutical Preparations
394
out of 1,043
62nd
Source: SEC filing on April 29, 2016.

Sumeray's colleagues

We found four more compensation records of executives who worked with Mark Sumeray at Aegerion Pharmaceuticals in 2014.

2014

Marc Beer

Aegerion Pharmaceuticals

Chief Executive Officer

2014

Mary Weger

Aegerion Pharmaceuticals

former Chief Performance Officer

2014

Mark Fitzpatrick

Aegerion Pharmaceuticals

Chief Financial Officer

2014

Martha Carter

Aegerion Pharmaceuticals

Chief Regulatory Officer

In-depth

You may also like